VERICI DX PLC
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
VRCI | IL
Overview
Corporate Details
- ISIN(s):
- GB00BM8HZD43
- LEI:
- 213800FI5WE4FVQ3G645
- Country:
- United Kingdom
- Address:
- AVON HOUSE, CF64 2EZ CARDIFF
- Website:
- https://www.vericidx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Verici Dx PLC is an immuno-diagnostics development company specializing in the kidney transplant market. The company develops and commercializes a suite of advanced prognostic and diagnostic tests that form a comprehensive kidney transplant platform. Leveraging artificial intelligence-assisted transcriptomic analysis, its technology deciphers RNA signatures to provide data-driven insights into the body's immune response. These tests offer personalized patient and organ response risk assessments to assist clinicians in medical management throughout the transplant process, from pre-transplant evaluation to late-stage monitoring. The core mission is to predict the risk of organ injury, rejection, and graft failure, ultimately improving patient outcomes and overall graft survival. The company also collaborates with biopharmaceutical and data science partners to foster innovation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-12 08:35 |
Regulatory News Service
Completion of CAP accreditation audit
|
English | 11.2 KB | ||
| 2025-11-06 08:20 |
Regulatory News Service
Provider Participation Agreement with Prime Health
|
English | 11.5 KB | ||
| 2025-11-03 08:30 |
Regulatory News Service
Completion of ISO 27001 surveillance audit
|
English | 11.1 KB | ||
| 2025-10-30 08:00 |
Remuneration Information
Options revision & Grant of new share options
|
English | 43.5 KB | ||
| 2025-10-01 17:55 |
Major Shareholding Notification
Holding(s) in Company
|
English | 26.0 KB | ||
| 2025-08-01 11:40 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.2 KB | ||
| 2025-07-31 18:28 |
Major Shareholding Notification
Holding(s) in Company
|
English | 40.6 KB | ||
| 2025-07-31 16:24 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.9 KB | ||
| 2025-07-31 08:00 |
Regulatory News Service
Tutivia™ abstracts for World Transplant Congress
|
English | 15.3 KB | ||
| 2025-07-30 15:32 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | ||
| 2025-07-30 15:26 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.5 KB | ||
| 2025-07-30 08:00 |
Post-Annual General Meeting Information
Result of Annual General Meeting
|
English | 17.8 KB | ||
| 2025-07-29 08:00 |
Share Issue/Capital Change
Result of WRAP Retail Offer
|
English | 27.3 KB | ||
| 2025-07-28 18:19 |
Major Shareholding Notification
Holding(s) in Company
|
English | 53.2 KB | ||
| 2025-07-28 17:55 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB |
Automate Your Workflow. Get a real-time feed of all VERICI DX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VERICI DX PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VERICI DX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
